Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
13,417 total articles
22nd Century Group, Inc. announced that the FDA has accepted for scientific review the company's renewal applications for their VLN® King and VLN® Menthol King cigarettes, the first combusted cigarettes authorized as Modified Risk Tobacco Products (MRTP). These renewals, if approved, will allow continued marketing of these reduced nicotine cigarett…
Skye Bioscience reported Q1 2026 financial results and provided a business update focusing on the advancement of its nimacimab obesity treatment program. The company initiated enrollment in Cohort 1 of the CBeyond Expansion Study, completed compatibility studies to support subcutaneous delivery, and is on track to report topline data in Q4 2026. Sk…
SEGG Media, a Nasdaq-listed sports and entertainment company, announced its expanded partnership with Soccerex by becoming the official headline sponsor for all 2026 and 2027 Soccerex events. The company is actively participating in Soccerex Europe 2026 in Amsterdam, engaging with key football stakeholders to grow its sports media and fan engagemen…
South Jersey Industries, Inc. has announced a cash tender offer to repurchase any and all of its outstanding 2018 Series A 3.70% Remarketable Junior Subordinated Notes due 2031 at $92 per $1,000 principal amount plus accrued interest. The offer expires on May 26, 2026, with settlement on May 29, 2026. Completion of the tender is contingent upon cer…
Kyivstar Group Ltd., Ukraine's leading digital operator listed on Nasdaq, held its 2026 Annual General Meeting where shareholders re-elected the current board and Chairman Kaan Terzioğlu, demonstrating continued confidence in the company's strategic direction. Kyivstar reported strong 2025 financial results with a 25.9% increase in revenue to USD 1…
Linkhome Holdings Inc. (Nasdaq: LHAI), an AI-driven real estate and fintech platform, has entered into a definitive agreement to acquire Mortgage One Group, a mortgage lending company operating in 18 U.S. states. This acquisition aims to integrate Mortgage One Group's lending infrastructure with Linkhome's AI technology to create an advanced AI-pow…
Octave Intelligence plc, a subsidiary of Hexagon AB, has filed and registered a prospectus for its admission to trading on Nasdaq Stockholm (SDRs) and Nasdaq New York (Class B ordinary shares). The distribution of Octave shares to Hexagon shareholders is scheduled with key trading dates in May 2026, marking Octave's debut as a publicly-traded compa…
Tevogen Bio Holdings Inc. announced a private investment in public equity (PIPE) financing of $3 million at $8 per prefunded warrant, representing a 14% premium over the previous closing price. The financing, backed by existing investor The Patel Family, LLP, aims to support ongoing operations, strategic growth, and general corporate purposes. The …
Avista Utilities has commenced operations of the first community-based microgrid in the region at the Dr. Martin Luther King Jr. Family Outreach Center in Spokane. The microgrid integrates solar power, battery storage, and natural gas to maintain reliable power during outages, allowing the center to remain operational and reduce energy costs. This …
Syndax Pharmaceuticals highlighted 12 abstracts featuring their FDA-approved menin inhibitor Revuforj (revumenib) accepted for presentation at the European Hematology Association (EHA) 2026 Congress. The data demonstrate strong activity across various subtypes of acute leukemia, favorable tolerability, promising post-transplant maintenance outcomes…
Plains All American Pipeline and Plains GP Holdings finalized the sale of Plains Midstream Canada, their natural gas liquids (NGL) business, to Keyera Corp for net proceeds of approximately $3.3 billion. The transaction supports debt reduction and strategic focus on crude oil midstream operations with more stable cash flows and reduced volatility. …
NEXGEL, a US-based healthcare and consumer products company specialized in hydrogel technologies, will report its first quarter 2026 financial results on May 15, 2026. The company will hold a conference call at 12:00 P.M. ET the same day to discuss the results. NEXGEL has a strong presence in healthcare, beauty, and OTC products and maintains strat…
Where Food Comes From, Inc., a company providing third-party verification for food production practices, announced it will release its Q1 2026 financial results before market opens on May 14, 2026, and hold an earnings conference call the same day.
ADT, Inc. has been recognized by Newsweek as the top smart home security company in America, ranking highly in categories such as America's Most Trustworthy Companies, Most Trusted Brands, and Best Customer Service. This recognition underscores ADT's long-standing commitment to reliable protection and customer trust for over 150 years.
Lemonade, a tech-driven insurance company listed on NYSE as LMND, has expanded its renters insurance product to Louisiana. The service offers customizable coverage through a mobile app at prices starting around $5 monthly, significantly lower than average market rates. This move marks another step in Lemonade's nationwide growth, targeting renters …
Kura Oncology and Kyowa Kirin will present updated Phase 1 KOMET-007 trial results showing high and durable response rates of ziftomenib in combination with standard chemotherapy (7+3) in newly diagnosed acute myeloid leukemia (AML) patients with NPM1 mutations or KMT2A rearrangements. The data feature a 96% complete response rate and deep molecula…
Skyward Specialty Insurance Group appoints Melissa Goto as President of E&S Brokerage and Inland Marine divisions, aiming to leverage her 25+ years of underwriting and leadership expertise to enhance strategic development and market position in specialty property and casualty insurance.
Aquestive Therapeutics has completed a new $150 million debt financing agreement with Oaktree Capital Management, providing improved financial flexibility by reducing near-term principal repayments and lowering interest rates. This capital structure enhancement is aimed at supporting the potential FDA approval and launch of Anaphylm, a novel sublin…
Geron Corporation announced the presentation of the first real-world evidence study of RYTELO (imetelstat) in patients with lower-risk myelodysplastic syndromes (LR-MDS) at the EHA 2026 Congress. The study, conducted at Moffitt Cancer Center, demonstrated safety and clinical efficacy consistent with the Phase 3 IMerge trial, including in heavily tr…
Agios Pharmaceuticals has submitted a supplemental New Drug Application (sNDA) to the FDA seeking accelerated approval for mitapivat, an oral pyruvate kinase activator, for the treatment of sickle cell disease. The submission follows FDA agreement on a confirmatory trial designed to demonstrate the drug's clinical benefit in reducing transfusion bu…
Star Bulk Carriers Corp., a major global dry bulk shipping company, has announced the results of its 2026 Annual Meeting of Shareholders held in Athens, Greece. The company reported the re-election of key directors and the appointment of Deloitte Certified Public Accountants S.A. as its independent auditors for the fiscal year 2026. Star Bulk highl…
Cogent Biosciences announced multiple presentations at the European Hematology Association (EHA) 2026 Congress, including pivotal oral presentation data from the APEX trial of bezuclastinib in Advanced Systemic Mastocytosis and preclinical data for their JAK2 V617F inhibitor program. These presentations underscore the company's progress in developi…
Disc Medicine announced multiple presentations at the European Hematology Association (EHA) 2026 Congress, including an oral presentation of phase 2 RALLY-MF trial data for DISC-0974 targeting anemia in myelofibrosis patients. The company also highlighted updates on bitopertin in erythropoietic protoporphyria (EPP) and ongoing trials for polycythem…
Caribou Biosciences announced that two of its investigational allogeneic CAR-T cell therapies, vispa-cel and CB-011, will be featured in oral presentations at the 2026 European Hematology Association Annual Meeting. These presentations will share updated clinical trial data demonstrating the therapies' potential in treating relapsed or refractory B…
Beam Therapeutics announced it will present updated Phase 1/2 clinical trial data for ristoglogene autogetemcel (risto-cel), an investigational gene-edited cell therapy aimed at treating sickle cell disease (SCD). The data underscores risto-cel's potential to restore red blood cell health and improve disease pathology by inducing fetal hemoglobin p…
